403 access
denied page
403 access denied page
The Page cannot be accessed. Please log in to access the page.
Intended for UK Breelib patients, their caregivers and treating healthcare professionals
This non-promotional website is part of the Breelib Patient Support Programme and is fully funded by Bayer
Information on adverse event and product technical complaint reporting can be found at the bottom of the page.
403 access
Reporting of side effects and quality complaints
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
You can also report side effects and quality complaints to Bayer Plc. Further information is available on the "contact" tab at www.bayer.co.uk.
By reporting side effects you can help provide more information on the safety of this medicine.
PP-BRE-GB-0586
Date of preparation: August 2023
UK Breelib patients
This website is intended for UK Breelib patients, their caregivers and treating healthcare professionals. Breelib.co.uk is part of the Breelib Patient Support Programme which is organised and fully funded by Bayer.
Personal medical advice
Always speak to your doctor or nurse for personal medical advice. Health information on this website is not intended to replace a consultation with a healthcare professional, nor is it intended to provide specific medical advice.
